Noerr advises investors on the sale of the BHT Group to Cantel Medical

Noerr has advised the shareholders of the BHT Group – with the assistance of Rigeto Unternehmerkapital GmbH – on the sale of BHT to Cantel Medical Corp. Cantel Medical Corp., a company listed on the New York Stock Exchange which produces and sells medical equipment, is taking over the BHT Group, the German market leader in the production of devices for automated endoscope reprocessing and flexible endoscope repair as well as related services.

The purchase price is around US$ 60.8 million. The transaction has been executed as a structured bid procedure.

Advisors to Rigeto Unternehmerkapital/seller: Noerr LLP

Dr Christoph Thiermann, Dr Georg Schneider (joint lead, both Private Equity), Dr Florian Niermeier (Healthcare, all Munich)

Associates: Dr Georg Langheld, Dr Michael Braun (both Corporate/M&A), Julia Hecht (Private Equity, all Munich)